Cresco Labs (CRLBF) Net Income (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Net Income came in at -$17.0 million in Q1 2026, down 11.68% YoY from -$19.3 million in Q1 2025, and up 80.06% on a QoQ basis from -$85.3 million in Q4 2025.
Cresco Labs (CRLBF) Net Income (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Net Income data on file, last reported at -$17.0 million in Q1 2026.
- Quarterly Net Income fell 11.68% year-over-year to -$17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$138.2 million (down 101.96% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
- Net Income climbed to -$17.0 million in Q1 2026, from -$85.3 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $55.6 million in Q2 2022 to a low of -$133.1 million in Q4 2022.
- A 5-year average of -$31.8 million and a median of -$22.0 million in 2025 frame the typical range for Net Income.
- Annual changes were most pronounced in 2022 — Net Income soared 222.04% — and 2025, when it slumped 1604.87%.
- Tracing CRLBF's Net Income over 5 years: stood at -$133.1 million in 2022, then surged by 115.6% to $20.8 million in 2023, then slumped by 72.69% to $5.7 million in 2024, then tumbled by 1604.87% to -$85.3 million in 2025, then soared by 80.06% to -$17.0 million in 2026.
- The last three Net Income figures came in at -$17.0 million (Q1 2026), -$85.3 million (Q4 2025), and -$22.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 15.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -85.34 Mn |
| Sep 30, 2025 | -21.97 Mn |
| Jun 30, 2025 | -13.89 Mn |
| Mar 31, 2025 | -15.23 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | -7.69 Mn |
| Jun 30, 2024 | -51.18 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | 20.77 Mn |
| Sep 30, 2023 | -113.45 Mn |
| Jun 30, 2023 | -43.46 Mn |
| Mar 31, 2023 | -27.81 Mn |
| Dec 31, 2022 | -133.10 Mn |
| Sep 30, 2022 | -67.19 Mn |
| Jun 30, 2022 | 55.65 Mn |
| Mar 31, 2022 | -23.68 Mn |
| Dec 31, 2021 | 35.15 Mn |
| Sep 30, 2021 | -219.60 Mn |
| Jun 30, 2021 | -45.60 Mn |